Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Enrolling by Invitation

Feasibility of Intermittent Fasting During Chemotherapy

NCT06645093

Conditions: Behavior, Cancer, Fasting, +10 more
Locations: Department of Nutrition, University of Oslo Oslo, Norway

View Trial Details

Enrolling by Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

NCT07410403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

NCT07348575

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Enrolling by Invitation

A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells

NCT07057583

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Enrolling by Invitation

Bone Marrow Grafting for Leukemia and Lymphoma

NCT00186147

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Enrolling by Invitation

BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas

NCT07258680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Enrolling by Invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

The Catholic University of Korea Seoul, Seocho-gu, South Korea

View Trial Details

Enrolling by Invitation

Tau PET Outcomes With Anti-amyloid Immunotherapies

NCT06723015

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +20 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Enrolling by Invitation

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

NCT06544798

Conditions: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Miami Cancer Institute at Baptist Health South Florida Miami, Florida, United States

University of Iowa Iowa City, Iowa, United States

University of Missouri Columbia, Missouri, United States

View Trial Details

Enrolling by Invitation

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

NCT07210047

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Far Eastern Memorial Hospital Taipei, Taiwan

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions